Abstract
The value of incorporating the patient voice into drug development is well established. Patient Preference studies (including discrete choice experiments [DCEs]) continue to rise in popularity to inform product design, trial design, product approval, and post-approval decisions. Recent methodological recommendations and regulatory guidance emphasize the importance of patient-centric preference study design.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
